The VII National Technology Awards XXI Century 2024 have already been held, where Proteos Biotech has been awarded as a leading company in the field of biotechnology specialized in the research and production of recombinant enzymes for applications in dermatology and aesthetic medicine.
The ceremony, organized by El Suplemento, took place at The Westin Palace Hotel in Madrid. It rewarded the evolution in the technological field, as well as technological research and education.
Since our foundation in 2010 and under the pbserum brand, we have experienced an exponential and constant growth, developing exclusive products for medical use and becoming a reference in the sector at international level, since we have presence in more than 50 countries.
Our facilities in Albacete and Madrid, have the technological and industrial capacity to meet the highest quality standards guaranteed by international certifications and makes possible the participation in numerous R+D+i projects, allowing us to develop two new lines: smartker and specific; which are added to a wide range of products to address the most frequent clinical needs related to the health and appearance of the skin, as well as to promote the rejuvenation and repair of the skin for marks such as stretch marks and acne scars.
In addition, our commitment to excellence and innovation is reflected in our ambitious scientific research program, which aims to offer new treatments for unresolved conditions and to add therapeutic alternatives to the more than 15 indications currently treated with recombinant enzymes, as well as to consolidate the medical evidence that encompasses several clinical studies already published and submitted, whose objective is to provide medical professionals with the security of having the best tools in their clinical practice.
We continue to focus on territorial expansion and collaboration with the medical community to improve the skin health of thousands of patients around the world.
